Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Chiasma Inc (CHMA)

Chiasma Inc (CHMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Chiasma Inc 140 Kendrick Street Building C East Needham MA 02494 USA

www.chiasmapharma.com P: 617-928-5300

Description:

Chiasma, Inc. is a biopharmaceutical company. The company's TPE(R) technology develops oral peptides and other molecules. Its primary product candidate consists of oral octreotide which is in different clinical trial. Chiasma, Inc. is based in Newton, USA.

Key Statistics

Overview:

Market Capitalization, $K 217,681
Shares Outstanding, K 57,894
Annual Sales, $ 1,110 K
Annual Net Income, $ -74,780 K
Last Quarter Sales, $ 1,920 K
Last Quarter Net Income, $ -30,550 K
60-Month Beta 1.28
% of Insider Shareholders 8.30%
% of Institutional Shareholders 61.68%
Float, K 53,089
% Float 91.70%

Growth:

1-Year Return -20.51%
3-Year Return 114.86%
5-Year Return 29.21%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 56.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 08/09/21
Earnings Per Share ttm -1.61
EPS Growth vs. Prev Qtr -53.13%
EPS Growth vs. Prev Year -36.11%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

CHMA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -113.57%
Return-on-Assets % -57.62%
Profit Margin % -6,736.94%
Debt/Equity 0.00
Price/Sales 209.38
Price/Cash Flow N/A
Price/Book 3.47
Book Value/Share 1.08
Interest Coverage -11.73
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar